Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can AI drafts help doctors explain Heart-Lung tests faster?

NCT ID NCT07829731

NEW Knowledge-focused Sponsor: Shanghai Zhongshan Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 21, 2026 · Last updated Sep 21, 2026

Summary

Cardiopulmonary exercise tests produce complex measurements that doctors must turn into clear explanations for patients. This randomized crossover study asks whether a physician-supervised GPT draft can match the clinical quality of a doctor-written response while saving time. Licensed physicians and clinical trainees respond to synthetic test scenarios in Chinese, either writing from scratch or editing a frozen GPT draft. Researchers compare the proportion of final responses that meet a clinical acceptability standard and measure how long each task takes.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Physician-supervised GPT-assisted drafting of patient-facing test explanations
What this could lead to
If it works, this could give doctors a faster way to write clear explanations of heart and lung exercise tests without lowering quality.
What could go wrong
The study uses synthetic cases and a frozen GPT draft, so results may not carry over to real patients or live AI tools. It measures written acceptability and speed, not whether patients understand or act on the advice.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Licensed physicians or institutionally recognized clinical trainees. * Able to read and write Chinese. * Experience in, or relevant training involving, cardiopulmonary exercise testing, cardiology, respiratory medicine, rehabilitation medicine, or related clinical interpretation within the previous 24 months. * Able to complete the computer-based study procedures. * Provision of written informed consent. Exclusion Criteria: * Participation in the development of the study case bank, reference answers, scoring manual, or frozen GPT-generated drafts. * Previous exposure to any Phase 2 study case. * Inability to complete the study tasks independently using the study computer interface. * A direct financial conflict of interest related to the evaluated artificial intelligence system. * Withdrawal of consent before completion of the assigned study procedures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiopulmonary exercise testing are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiopulmonary exercise testing Clinical decision support systems

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Zhongshan Hospital, Fudan University

    Shanghai, Shanghai Municipality, 200032, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.